MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617058440 A) filed by Merck Sharp & Dohme LLC on May 07, 2026, for Human Nectin-4 Binders.
Inventors include Jeon, Albert Byungyun; Vanegas, Sandra Isabel; Vroom, Karin; and Yearley, Jennifer H..
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present disclosure provides isolated antibodies that specifically bind to human Nectin-4, antigen-binding fragments of such antibodies, and kits comprising the anti- Nectin-4 antibodies or binding fragments and a set of reagents for detecting a complex of the antibody or antigen-binding fragment thereof bound to human Nectin-4. The antibodies and antigen-binding fragments of this disclosure are useful for detection of human Nectin-4 expression in tissue samples and for treating cancer in a subject. Nucleic acid molecules encoding the antibodies and antigen-binding fragments of this disclosure, expression vectors, and host cells for expressing the antibodies and antigen-binding fragments are also provided.
Disclaimer: Curated by HT Syndication.
